Home / Amoxicillin and Beta-Lactamase Inhibitor / Czechia
CZ ATC J01CR02 · updated 2 Nov 2026
Amoxicillin and Beta-Lactamase Inhibitor shortage in Czechia
Is there an Amoxicillin and Beta-Lactamase Inhibitor shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Amoxicillin and Beta-Lactamase Inhibitor products are reported short in Czechia, the first since 5 Aug 2026. The company estimate for the return is 13 Nov 2026 (latest 27 Nov 2026). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland, Switzerland, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | AMOKSIKLAV 1 G 875MG/125MG 875MG/125MG TBL FLM 21 | Lek Pharmaceuticals d.d., Ljubljana | 5 Aug 2026 | 13 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | AMOXICILLIN/CLAVULANIC ACID OLIKLA 1000MG/200MG 1000MG/200MG INJ/INF PLV SOL 10 | Olikla s.r.o., Kostelec nad Černými Lesy | 1 Oct 2026 | 23 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | PENLAC 875MG/125MG 875MG/125MG TBL FLM 14 | Zentiva, k.s., Praha | 2 Nov 2026 | 27 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.